Antalis, T. M., La Linn, M., Donnan, K., Mateo, L., Gardner, J., Dickinson, J. L., . . . Suhrbier, A. (1998). The Serine Proteinase Inhibitor (Serpin) Plasminogen Activation Inhibitor Type 2 Protects against Viral Cytopathic Effects by Constitutive Interferon α/β Priming. The Rockefeller University Press.

Antalis, Toni M., May La Linn, Karen Donnan, Luis Mateo, Joy Gardner, Joanne L. Dickinson, Kathy Buttigieg, and Andreas Suhrbier. The Serine Proteinase Inhibitor (Serpin) Plasminogen Activation Inhibitor Type 2 Protects against Viral Cytopathic Effects By Constitutive Interferon α/β Priming. The Rockefeller University Press, 1998.

Antalis, Toni M., et al. The Serine Proteinase Inhibitor (Serpin) Plasminogen Activation Inhibitor Type 2 Protects against Viral Cytopathic Effects By Constitutive Interferon α/β Priming. The Rockefeller University Press, 1998.